Results 111 to 120 of about 690 (120)
Some of the next articles are maybe not open access.

Utilizing Physiologically Based Pharmacokinetic Modeling and Virtual Simulation for Simvastatin Tablets to Evaluate the Sensitivity of Using Parent vs Metabolite as Analyte on Bioequivalence Assessment

The AAPS Journal
Typically, parent drug is measured for bioequivalence (BE) assessment because it's more sensitive to detect formulation differences, compared to its metabolite(s). For simvastatin immediate release (IR) tablets, current product-specific guidance (PSG) recommends measuring both parent and metabolite but taking metabolite as supportive data.
Yi-Hsien Cheng   +4 more
openaire   +2 more sources

Virtual Workshop Report: Approaches, Regulatory Challenges, and Advances in Bioequivalence, Dissolution Testing, and Biowaivers: Manila, Philippines, February 22-24, 2023

Dissolution Technologies, 2023
James E. Polli   +8 more
openaire   +1 more source

Integrated Pirana–Simcyp Virtual Bioequivalence converts PBPK simulations into rapid, reproducible, and extensible bioequivalence decisions

Craig, James   +9 more
openaire   +1 more source

PBPK-Based Virtual Bioequivalence Trials to Guide Drug Development

Amitava Mitra   +2 more
openaire   +1 more source

Successful bioequivalence prediction of immediate-release vortioxetine tablets through prospective virtual crossover and parallel trials

Journal of Pharmaceutical Sciences
Dorota Danielak   +14 more
openaire   +1 more source

Home - About - Disclaimer - Privacy